ArticleInternational journal of hematology2016

Phase I dose escalation study of high dose carfilzomib monotherapy for Japanese patients with relapsed or refractory multiple myeloma.

Shinsuke Iida et al.PubMed ↗Publisher ↗

No numbers read from the abstract.